Search
Search Results
##search.searchResults.foundPlural##
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2771PDF: 916HTML: 7314 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3246PDF: 1323HTML: 2618 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
818PDF: 480HTML: 1290 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4037PDF: 1213HTML: 1946Table 1: 181 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3811Suppl. Files: 1075PDF: 1039Html: 157 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1892PDF: 1076HTML: 1886Lung computed tomography CT scan image: 190 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1333PDF: 743HTML: 933 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
949PDF: 524HTML: 714 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7353PDF: 2384HTML: 1713Table 1.: 190Table 2.: 204Table 3.: 185Table 4.: 182 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3483PDF: 2372HTML: 1433 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3651PDF: 1217HTML: 3872Untitled: 195Untitled: 244 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2179PDF: 919HTML: 286 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7787PDF: 4052HTML: 7317 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3197PDF: 1212HTML: 8093 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3503PDF: 1455HTML: 4352CoverLetter: 175Figure1: 182 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4007PDF: 1124HTML: 1923Fig.1: 209Fig. 2: 104Table 1: 192Table2: 206Table 3: 186 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4239PDF: 1346HTML: 2029 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3276PDF: 568HTML: 639 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3170PDF: 985HTML: 1996 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1229PDF: 461HTML: 18551Figure 1: 154Figure 2: 138Figure 3: 156Figure 4: 189Figure 5: 160 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2031PDF: 1485HTML: 264 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1217PDF: 637HTML: 7717 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3477PDF: 1154HTML: 4984Incidence age-standardized rates for HL across the Mediterranean basin: 184 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1998PDF: 1835HTML: 336 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
667PDF: 510HTML: 201







